Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils

Microbiology (United Kingdom)

Volumn 160, Issue PART 8, 2014, Pages 1714-1726

  Zhu, Hua ^a   Swierstra, Jasper ^b   Wu, Changsheng ^a   Girard, Geneviéve ^a   Choi, Young Hae ^a   Van Wamel, Willem ^b   Sandiford, Stephanie K ^a   van Wezel, Gilles P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,8 TRIMETHOXY 3 METHYLISOCOUMARIN; 6,7,8 TRIMETHOXY 3 METHYLISOCOUMARIN; ANTIBIOTIC AGENT; BORRELIDIN; PHENAZINE DERIVATIVE; RESISTOMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MANUFACTURE; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECIUM; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PHYLOGENY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOIL MICROFLORA; STAPHYLOCOCCUS AUREUS; STREPTOMYCES;

EID: 84905245366     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.078295-0     Document Type: Article

References (59)

1. Ahmed, S., Craney, A., Pimentel-Elardo, S. M.; Nodwell, J. R. (2013). A synthetic, species-specific activator of secondary metabolism and sporulation in Streptomyces coelicolor. ChemBioChem 14, 83- 91.
2. Baltz, R. H. (2007). Antimicrobials from actinomycetes: back to the future. Microbe 2, 125-131.
3. Baltz, R. H. (2008). Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 8, 557-563.
4. Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A. M., Challis, G. L., Thomson, N. R., James, K. D., Harris, D. E., Quail, M. A., Kieser, H.; other authors (2002). Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417, 141-147.
5. Boucher, H. W.; Corey, G. R. (2008). Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 (5), S344-S349.
6. Burt, S. (2004). Essential oils: their antibacterial properties and potential applications in foods - a review. Int J Food Microbiol 94, 223-253.
7. Challis, G. L.; Hopwood, D. A. (2003). Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc Natl Acad Sci USA 100 (2), 14555-14561.
8. Chater, K. F., Biró, S., Lee, K. J., Palmer, T.; Schrempf, H. (2010). The complex extracellular biology of Streptomyces. FEMS Microbiol Rev 34, 171-198.
9. Claessen, D., Rozen, D. E., Kuipers, O. P., S;gaard-Andersen, L.; van Wezel, G. P. (2014). Bacterial solutions to multicellularity; a tale of biofilms, filaments and fruiting bodies. Nat Rev Microbiol 12, 115- 124.
10. CLSI (2004). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard. Wayne, PA: Clinical and Laboratory Standards Institute.
11. Colson, S., van Wezel, G. P., Craig, M., Noens, E. E., Nothaft, H., Mommaas, A. M., Titgemeyer, F., Joris, B.; Rigali, S. (2008). The chitobiose-binding protein, DasA, acts as a link between chitin utilization and morphogenesis in Streptomyces coelicolor. Microbiology 154, 373-382.
12. Craney, A., Ozimok, C., Pimentel-Elardo, S. M., Capretta, A.; Nodwell, J. R. (2012). Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem Biol 19, 1020-1027.
13. Cruz-Morales, P., Vijgenboom, E., Iruegas-Bocardo, F., Girard, G., Yáñez-Guerra, L. A., Ramos-Aboites, H. E., Pernodet, J. L., Anné, J., van Wezel, G. P.; Barona-Gómez, F. (2013). The genome sequence of Streptomyces lividans 66 reveals a novel tRNA-dependent peptide biosynthetic system within a metal-related genomic island. Genome Biol Evol 5, 1165-1175.
14. Davies, J. C. (2002). Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev 3, 128-134.
15. Fischbach, M. A.; Walsh, C. T. (2009). Antibiotics for emerging pathogens. Science 325, 1089-1093.
16. Girard, G., Traag, B. A., Sangal, V., Mascini, N., Hoskisson, P. A., Goodfellow, M.; van Wezel, G. P. (2013). A novel taxonomic marker that discriminates between morphologically complex actinomycetes. Open Biol 3, 130073.
17. Giske, C. G., Monnet, D. L., Cars, O., Carmeli, Y.; ReAct-Action on Antibiotic Resistance (2008). Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52, 813-821.
18. Habibi, D., Ogloff, N., Jalili, R. B., Yost, A., Weng, A. P., Ghahary, A.; Ong, C. J. (2012). Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia. Invest New Drugs 30, 1361-1370.
19. Haupt, I., Wähnert, U., Pitra, C., Löber, G., Luck, G.; Eckardt, K. (1975). Effects of the antibiotic resistomycin on the synthesis of macromolecules. Z Allg Mikrobiol 15, 411-421.
20. Hayakawa, M.; Nonomura, H. (1987). Humic acid-vitamin agar, a new medium for the selective isolation of soil actinomycetes. J Ferment Technol 65, 501-509.
21. Hayakawa, M.; Nonomura, H. (1989). A new method for the intensive isolation of actinomycetes from soil. Actinomycetologica 3, 95-104.
22. Hegde, V. R., Wittreich, H., Patel, M. G., Horan, A. C., Hart, R. F., Troyanovich, J. J., Puar, M. S.; Gullo, V. P. (1989). Naturally produced isocoumarins: inhibitors of calmodulin-sensitive cyclic guanosine 39,59-monophosphate phosphodiesterase. J Ind Microbiol 4, 209-213.
23. Hopwood, D. A. (2007). Streptomyces in Nature and Medicine: The Antibiotic Makers. New York: Oxford University Press
24. Karnetová, J., Tax, J., Stajner, K., Vank, Z.; Krumphanzl, V. (1983). Production of phenazines by Streptomyces cinnamonensis. Folia Microbiol (Praha) 28, 51-53.
25. Katoh, K., Asimenos, G.; Toh, H. (2009). Multiple alignment of DNA sequences with MAFFT. Methods Mol Biol 537, 39-64.
26. Kieser, T., Bibb, M. J., Buttner, M. J., Chater, K. F.; Hopwood, D. A. (2000). Practical Streptomyces Genetics. Norwich: The John Innes Foundation.
27. Kim, H. K., Saifullah Khan, S., Wilson, E. G., Kricun, S. D., Meissner, A., Goraler, S., Deelder, A. M., Choi, Y. H.; Verpoorte, R. (2010). Metabolic classification of South American Ilex species by NMR-based metabolomics. Phytochemistry 71, 773-784.
28. Klevens, R. M., Edwards, J. R., Tenover, F. C., McDonald, L. C., Horan, T., Gaynes, R.; National Nosocomial Infections Surveillance System (2006). Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42, 389-391.
29. Küster, E.; Williams, S. T. (1964). Selection of media for isolation of Streptomycetes. Nature 202, 928-929.
30. Lazzarini, A., Cavaletti, L., Toppo, G.; Marinelli, F. (2000). Rare genera of actinomycetes as potential producers of new antibiotics. Antonie van Leeuwenhoek 78, 399-405.
31. MacNeil, D. J., Gewain, K. M., Ruby, C. L., Dezeny, G., Gibbons, P. H.; MacNeil, T. (1992). Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. Gene 111, 61-68.
32. Miyadoh, S. (1993). Research on antibiotic screening in Japan over the last decade: a producing microorganism approach. Actinomycetologica 7, 100-106.
33. Nair, R.; Chanda, S. (2006). Activity of some medicinal plants against certain pathogenic bacterial strains. Indian J Pharmacol 38, 142-144.
34. Nass, G.; Hasenbank, R. (1970). Effect of Borrelidin on the threonyl-tRNA-synthetase activity and the regulation of threonine-biosynthetic enzymes in Saccharomyces cerivisiae. Mol Gen Genet 108, 28-32.
35. Ng, Z. Y.; Amsaveni, S. (2012). Isolation, screening and characterization of antibiotic-producing actinomycetes from rhizo-sphere region of different plants from a farm of Sungai Ramal Luar, Malaysia. J Adv Biomed Pathobiol Res 2, 96-107.
36. Nothaft, H., Rigali, S., Boomsma, B., Swiatek, M., McDowall, K. J., van Wezel, G. P.; Titgemeyer, F. (2010). The permease gene nagE2 is the key to N-acetylglucosamine sensing and utilization in Streptomyces coelicolor and is subject to multi-level control. Mol Microbiol 75, 1133-1144.
37. Ohnishi, Y., Ishikawa, J., Hara, H., Suzuki, H., Ikenoya, M., Ikeda, H., Yamashita, A., Hattori, M.; Horinouchi, S. (2008). Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol 190, 4050-4060.
38. Okami, Y.; Hotta, K. (1988). Search and discovery of new antibiotics. In Actinomycetes in Biotechnology, pp. 33-67. Edited by M. Goodfellow, S. T. Williams ; M. Mordarski. London: Academic Press.
39. Payne, D. J., Gwynn, M. N., Holmes, D. J.; Pompliano, D. L. (2007). Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6, 29-40.
40. Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197, 1079-1081.
41. Rigali, S., Nothaft, H., Noens, E. E., Schlicht, M., Colson, S., Müller, M., Joris, B., Koerten, H. K., Hopwood, D. A.; other authors (2006). The sugar phosphotransferase system of Streptomyces coelicolor is regulated by the GntR-family regulator DasR and links N-acetylglu-cosamine metabolism to the control of development. Mol Microbiol 61, 1237-1251.
42. Rigali, S., Titgemeyer, F., Barends, S., Mulder, S., Thomae, A. W., Hopwood, D. A.; van Wezel, G. P. (2008). Feast or famine: the global regulator DasR links nutrient stress to antibiotic production by Streptomyces. EMBO Rep 9, 670-675.
43. Roggo, B. E., Petersen, F., Delmendo, R., Jenny, H. B., Peter, H. H.; Roesel, J. (1994). 3-Alkanoyl-5-hydroxymethyl tetronic acid homo-logues and resistomycin: new inhibitors of HIV-1 protease. I. Fermentation, isolation and biological activity. J Antibiot (Tokyo) 47, 136-142.
44. Römer, A. (1982). H NMR spectra of substituted phenazines. Org Magnet Res 19, 66-68.
45. Sajid, I., Shaaban, K. A.; Hasnain, S. (2011). Antitumour compounds from a saline soil isolate, Streptomyces griseoincarnatus CTF15. Nat Prod Res 25, 549-559.
46. Sánchez, S., Chávez, A., Forero, A., García-Huante, Y., Romero, A., Sánchez, M., Rocha, D., Sánchez, B., Avalos, M.; other authors (2010). Carbon source regulation of antibiotic production. J Antibiot (Tokyo) 63, 442-459.
47. Shiono, Y., Shiono, N., Seo, S., Oka, S.; Yamazaki, Y. (2002). Effects of polyphenolic anthrone derivatives, resistomycin and hypercin, on apoptosis in human megakaryoblastic leukemia CMK-7 cell line. Z Naturforsch C 57, 923-929.
48. Singh, L. S., Baruah, I.; Bora, T. C. (2006). Actinomycetes of Loktak habitat: isolation and screening for antimicrobial activities. Biotechnology 5, 217-221.
49. Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., Jr ; Infectious Diseases Society of America (2008). The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46, 155-164.
50. Światek, M. A., Tenconi, E., Rigali, S.; van Wezel, G. P (2012). Functional analysis of the N-acetylglucosamine metabolic genes of Streptomyces coelicolor and role in control of development and antibiotic production. J Bacteriol 194, 1136-1144.
51. Takahashi, Y.; Omura, S. (2003). Isolation of new actinomycete strains for the screening of new bioactive compounds. J Gen Appl Microbiol 49, 141-154.
52. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M.; Kumar, S. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28, 2731-2739.
53. Thakur, D., Yadav, A., Gogoi, B. K.; Bora, T. C. (2007). Isolation and screening of Streptomyces in soil of protected forest areas from the states of Assam and Tripura, India, for antimicrobial metabolites. J Med Mycol 17, 242-249.
54. Tran, M. C., Claros, M. C.; Goldstein, E. J. (2013). Therapy of Clostridium difficile infection: perspectives on a changing paradigm. Expert Opin Pharmacother 14, 2375-2386.
55. van Wezel, G. P.; McDowall, K. J. (2011). The regulation of the secondary metabolism of Streptomyces: new links and experimental advances. Nat Prod 28, 1311-1333.
56. van Wezel, G. P., McKenzie, N. L.; Nodwell, J. R. (2009). Applying the genetics of secondary metabolism in model actinomycetes to the discovery of new antibiotics. Methods Enzymol 458, 117-141.
57. Vijayabharathi, R., Bruheim, P., Andreassen, T., Raja, D. S., Devi, P. B., Sathyabama, S.; Priyadarisini, V. B. (2011). Assessment of resistomycin, as an anticancer compound isolated and characterized from Streptomyces aurantiacus 5. J Microbiol 49, 920-926.
58. Wakabayashi, T., Kageyama, R., Naruse, N., Tsukahara, N., Funahashi, Y., Kitoh, K.; Watanabe, Y. (1997). Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model. J Antibiot (Tokyo) 50, 671-676.
59. Zhu, H., Sandiford, S. K.; van Wezel, G. P. (2014). Triggers and cues that activate antibiotic production by actinomycetes. J Ind Microbiol Biotechnol 41, 371-386.